BeOne Medicines AG (HKG:6160)

BeOne Medicines AG Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	13,934	19,178	22,491	26,689	27,797	9,022
Short-Term Investments	-	-	-	4,588	14,261	21,340
Cash & Short-Term Investments	29,123	19,178	22,491	31,278	42,058	30,362
Cash Growth	52.97%	-14.73%	-28.09%	-25.63%	38.52%	343.72%
Accounts Receivable	6,135	4,936	2,539	1,194	3,069	394.35
Other Receivables	68.97	239.61	268.45	178.06	108.39	125.81
Receivables	6,204	5,176	2,807	1,372	3,177	520.15
Inventory	3,780	3,613	2,951	1,947	1,541	582.96
Prepaid Expenses	-	360.33	625.83	573.1	881.82	376.93
Restricted Cash	-	67.97	81.35	1.35	2.08	2
Other Current Assets	996.58	740.22	850.02	742.45	707.15	541.92
Total Current Assets	40,104	29,135	29,806	35,914	48,368	32,386
Property, Plant & Equipment	11,548	12,538	10,065	6,593	4,479	2,927
Long-Term Investments	715.44	941.09	635.66	633.02	640.29	322.15
Goodwill	-	-	-	-	0.69	0.71
Other Intangible Assets	1,235	372.95	405.16	280.14	296.53	32.64
Long-Term Deferred Tax Assets	-	-	-	-	-	430.64
Other Long-Term Assets	252.62	230.34	253.27	578.75	438.51	466.04
Total Assets	54,076	43,217	41,165	43,999	54,223	36,565
Accounts Payable	4,368	2,956	2,234	2,033	1,667	1,514
Accrued Expenses	1,635	5,697	4,431	3,311	3,394	2,545
Short-Term Debt	5,466	5,963	4,678	2,171	2,698	2,185
Current Portion of Long-Term Debt	1,489	252.42	202.67	97.51	17.94	2
Current Portion of Leases	-	128.29	155.65	165.82	139.28	90.71
Current Income Taxes Payable	541.5	189.27	162.74	173.73	135.91	133.05
Current Unearned Revenue	-	-	-	1,475	1,191	-
Other Current Liabilities	3,230	980.93	970.18	700.7	918.13	549.73
Total Current Liabilities	16,730	16,167	12,835	10,129	10,161	7,020
Long-Term Debt	994.52	1,215	1,401	1,443	1,284	1,199
Long-Term Leases	365.89	323.18	157.78	238.07	273.42	192.05
Long-Term Unearned Revenue	207.16	221.34	242.54	553.17	1,694	320.81
Pension & Post-Retirement Benefits	-	119.74	106.33	53.52	49.64	52.97
Long-Term Deferred Tax Liabilities	278.61	306.61	116.96	110.33	90.01	70.46
Other Long-Term Liabilities	6,165	542.26	1,222	1,240	1,713	2,450
Total Liabilities	24,741	18,895	16,082	13,766	15,265	11,304
Common Stock	0.97	1.01	0.96	0.93	0.84	0.77
Additional Paid-In Capital	89,364	88,231	82,245	79,600	71,092	48,409
Retained Earnings	-61,528	-62,822	-56,458	-48,835	-32,249	-23,194
Comprehensive Income & Other	1,498	-1,087	-705.16	-533.96	114.03	45.32
Total Common Equity	29,335	24,322	25,083	30,233	38,958	25,261
Shareholders' Equity	29,335	24,322	25,083	30,233	38,958	25,261
Total Liabilities & Equity	54,076	43,217	41,165	43,999	54,223	36,565
Total Debt	8,316	7,882	6,596	4,115	4,413	3,669
Net Cash (Debt)	20,807	11,296	15,895	27,162	37,645	26,694
Net Cash Growth	78.53%	-28.94%	-41.48%	-27.85%	41.03%	443.48%
Net Cash Per Share	185.59	107.28	152.27	263.37	405.73	319.79
Filing Date Shares Outstanding	110.66	106.72	104.58	104.32	102.68	91.6
Total Common Shares Outstanding	110.62	106.72	104.58	104.32	102.68	91.6
Working Capital	23,374	12,968	16,971	25,786	38,207	25,367
Book Value Per Share	265.18	227.91	239.85	289.81	379.42	275.77
Tangible Book Value	28,100	23,949	24,678	29,953	38,660	25,227
Tangible Book Value Per Share	254.02	224.41	235.97	287.13	376.52	275.40
Land	-	477.98	464.35	451.66	416	-
Buildings	-	4,437	1,643	1,534	915.3	728.12
Machinery	-	3,541	2,781	2,308	1,511	1,145
Construction In Progress	-	4,774	5,252	2,025	1,187	560.02
Leasehold Improvements	-	472.11	426.33	370.97	319.46	245.76

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.